SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis.

Publication date: Feb 08, 2025

To protect healthcare workforce during the COVID-19 pandemic, rigorous efforts were made to reduce infection rates among healthcare workers (HCWs), especially prior to vaccine availability. This study aimed to investigate the prevalence of SARS-CoV-2 infections among HCWs and identify potential risk factors associated with transmission. We searched MEDLINE, Embase, and Google Scholar from 1 December 2019 to 5 February 2024. From 498 initial records, 190 articles were reviewed, and 63 studies were eligible. ROBINS-E tool revealed a lower risk of bias in several domains; however, some concerns related to confounding and exposure measurement were identified. Globally, 11% (95% confidence interval (CI) 9-13) of 283,932 HCWs were infected with SARS-CoV-2. Infection rates were associated with a constellation of risk factors and major circulating SARS-CoV-2 variants. Household exposure (odds ratio (OR) 7. 07; 95% CI 3. 93-12. 73), working as a cleaner (OR 2. 72; 95% CI 1. 39-5. 32), occupational exposure (OR 1. 79; 95% CI 1. 49-2. 14), inadequate training on infection prevention and control (OR 1. 46; 95% CI 1. 14-1. 87), insufficient use of personal protective equipment (OR 1. 45; 95% CI 1. 14-1. 84), performing aerosol generating procedures (OR 1. 36; 95% CI 1. 21-1. 52) and inadequate hand hygiene (OR 1. 17; 95% CI 0. 79-1. 73) were associated with an increased SARS-CoV-2 infection. Conversely, history of quarantine (OR 0. 23; 95% CI 0. 08-0. 60) and frequent decontamination of high touch areas (OR 0. 52; 95% CI 0. 42-0. 64) were protective factors against SARS-CoV-2 infection. This study quantifies the substantial global burden of SARS-CoV-2 infection among HCWs. We underscore the urgent need for effective infection prevention and control measures, particularly addressing factors such as household exposure and occupational practices by HCWs, including cleaning staff.

Open Access PDF

Concepts Keywords
December COVID-19
Decontamination COVID-19
Google Health Personnel
Healthcare Healthcare workers (HCWs)
Scholar Household
Humans
Infection
Occupational
Occupational Exposure
Prevalence
Quarantine
Risk factor
Risk Factors
SARS-CoV-2
SARS-CoV-2

Semantics

Type Source Name
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH infection
disease IDO history
drug DRUGBANK Etoperidone
disease MESH emerging infectious diseases
disease MESH morbidity
disease MESH Influenza
disease MESH Infectious Diseases
drug DRUGBANK Coenzyme M
drug DRUGBANK Medical air
disease IDO susceptibility
disease IDO quality
disease IDO protein
disease MESH hospital infection
disease IDO intervention
disease IDO process
disease IDO country
drug DRUGBANK Trimebutine
disease IDO production
drug DRUGBANK Methionine
disease IDO primary infection
disease MESH breakthrough infection
drug DRUGBANK Oxygen
disease IDO infectivity
disease IDO contact tracing
disease MESH viral infections
disease MESH Middle East respiratory syndrome
disease IDO role
disease MESH community transmission
disease MESH Secondary infections
disease IDO host
disease MESH reinfections
disease MESH emergency
disease IDO immunosuppression
disease MESH lifestyle
disease MESH complications
drug DRUGBANK Trestolone
disease IDO pathogen
drug DRUGBANK Ranitidine
disease MESH virus shedding
disease IDO facility
disease MESH Long COVID
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Medium-chain triglycerides
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)